These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27777419)

  • 1. Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein.
    Kaur G; Pawlik M; Gandy SE; Ehrlich ME; Smiley JF; Levy E
    Mol Psychiatry; 2017 Jul; 22(7):981-989. PubMed ID: 27777419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers.
    Gandy S; Simon AJ; Steele JW; Lublin AL; Lah JJ; Walker LC; Levey AI; Krafft GA; Levy E; Checler F; Glabe C; Bilker WB; Abel T; Schmeidler J; Ehrlich ME
    Ann Neurol; 2010 Aug; 68(2):220-30. PubMed ID: 20641005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
    Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
    Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice.
    Umeda T; Tomiyama T; Kitajima E; Idomoto T; Nomura S; Lambert MP; Klein WL; Mori H
    Life Sci; 2012 Dec; 91(23-24):1169-76. PubMed ID: 22273754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplodeficiency of Cathepsin D does not affect cerebral amyloidosis and autophagy in APP/PS1 transgenic mice.
    Cheng S; Wani WY; Hottman DA; Jeong A; Cao D; LeBlanc KJ; Saftig P; Zhang J; Li L
    J Neurochem; 2017 Jul; 142(2):297-304. PubMed ID: 28429406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo.
    Gandy S; Zhang YW; Ikin A; Schmidt SD; Bogush A; Levy E; Sheffield R; Nixon RA; Liao FF; Mathews PM; Xu H; Ehrlich ME
    J Neurochem; 2007 Aug; 102(3):619-26. PubMed ID: 17630980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntingtin associated protein 1 regulates trafficking of the amyloid precursor protein and modulates amyloid beta levels in neurons.
    Yang GZ; Yang M; Lim Y; Lu JJ; Wang TH; Qi JG; Zhong JH; Zhou XF
    J Neurochem; 2012 Sep; 122(5):1010-22. PubMed ID: 22731248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
    España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
    Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.
    Casas C; Sergeant N; Itier JM; Blanchard V; Wirths O; van der Kolk N; Vingtdeux V; van de Steeg E; Ret G; Canton T; Drobecq H; Clark A; Bonici B; Delacourte A; Benavides J; Schmitz C; Tremp G; Bayer TA; Benoit P; Pradier L
    Am J Pathol; 2004 Oct; 165(4):1289-300. PubMed ID: 15466394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macroautophagy is not directly involved in the metabolism of amyloid precursor protein.
    Boland B; Smith DA; Mooney D; Jung SS; Walsh DM; Platt FM
    J Biol Chem; 2010 Nov; 285(48):37415-26. PubMed ID: 20864542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraneuronal amyloid β oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo.
    Umeda T; Tomiyama T; Sakama N; Tanaka S; Lambert MP; Klein WL; Mori H
    J Neurosci Res; 2011 Jul; 89(7):1031-42. PubMed ID: 21488093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice.
    Dixit S; Bernardo A; Walker JM; Kennard JA; Kim GY; Kessler ES; Harrison FE
    ACS Chem Neurosci; 2015 Apr; 6(4):570-81. PubMed ID: 25642732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal Dysregulation in the Murine App
    Whyte LS; Hassiotis S; Hattersley KJ; Hemsley KM; Hopwood JJ; Lau AA; Sargeant TJ
    Neuroscience; 2020 Mar; 429():143-155. PubMed ID: 31917339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal dysfunction in a mouse model of Sandhoff disease leads to accumulation of ganglioside-bound amyloid-β peptide.
    Keilani S; Lun Y; Stevens AC; Williams HN; Sjoberg ER; Khanna R; Valenzano KJ; Checler F; Buxbaum JD; Yanagisawa K; Lockhart DJ; Wustman BA; Gandy S
    J Neurosci; 2012 Apr; 32(15):5223-36. PubMed ID: 22496568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology.
    Price KA; Varghese M; Sowa A; Yuk F; Brautigam H; Ehrlich ME; Dickstein DL
    Mol Neurodegener; 2014 Oct; 9():41. PubMed ID: 25312309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer's disease: analysis of Osaka mutation-knockin mice.
    Umeda T; Kimura T; Yoshida K; Takao K; Fujita Y; Matsuyama S; Sakai A; Yamashita M; Yamashita Y; Ohnishi K; Suzuki M; Takuma H; Miyakawa T; Takashima A; Morita T; Mori H; Tomiyama T
    Acta Neuropathol Commun; 2017 Jul; 5(1):59. PubMed ID: 28760161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.